Document ID: FDA-2018-N-1967-0006
Agency: fda
Document Type: Notice
Title: Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals
Posted Date: 2022-03-03T05:00Z

[Federal Register Volume 87, Number 42 (Thursday, March 3, 2022)]
[Notices]
[Page 12175]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-04409]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket Nos. FDA-2021-N-0918; FDA-2018-N-1967; FDA-2009-D-0268; and 
FDA-2019-N-3077]

Agency Information Collection Activities; Announcement of Office 
of Management and Budget Approvals

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or Agency) is publishing 
a list of information collections that have been approved by the Office 
of Management and Budget (OMB) under the Paperwork Reduction Act of 
1995.

FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Operations, 
Food and Drug Administration, Three White Flint North, 10A-12M, 11601 
Landsdown St., North Bethesda, MD 20852, 301-796-7726, 
[email protected].

SUPPLEMENTARY INFORMATION: The following is a list of FDA information 
collections recently approved by OMB under section 3507 of the 
Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control 
number and expiration date of OMB approval for each information 
collection are shown in table 1. Copies of the supporting statements 
for the information collections are available on the internet at 
https://www.reginfo.gov/public/do/PRAMain. An Agency may not conduct or 
sponsor, and a person is not required to respond to, a collection of 
information unless it displays a currently valid OMB control number.

        Table 1--List of Information Collections Approved By OMB
------------------------------------------------------------------------
                                            OMB control    Date approval
           Title of collection                  No.           expires
------------------------------------------------------------------------
Labeling Requirements for Human                0910-0572       1/31/2025
 Prescription Drug and Biological
 Products...............................
Biosimilar User Fee Program.............       0910-0718       1/31/2025
Labeling of Certain Beers Subject to the       0910-0728       1/31/2025
 Labeling Jurisdiction of the FDA.......
Obtaining Information to Understand and        0910-0883       2/28/2025
 Challenges and Opportunities
 Encountered by Compounding Outsourcing
 Facilities.............................
------------------------------------------------------------------------

    Dated: February 23, 2022.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2022-04409 Filed 3-2-22; 8:45 am]
BILLING CODE 4164-01-P